AYTU BioPharma
AYTU
66 hedge funds and large institutions have $12.4M invested in AYTU BioPharma in 2020 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 9 closing their positions.
367% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 9
305% more capital invested
Capital invested by funds: $3.05M → $12.4M (+$9.3M)
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
100% more funds holding
Funds holding: 33 → 66 (+33)
0.02% more ownership
Funds ownership: 0.01% → 0.04% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.53M |
| 2 |
BlackRock
New York
|
+$1.63M |
| 3 |
Jane Street
New York
|
+$441K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$430K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$425K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$368K |
| 2 |
Renaissance Technologies
New York
|
-$363K |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$209K |
| 4 |
SC
Searle & Co
Greenwich,
Connecticut
|
-$199K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$62K |
AYTU Hedge Fund Activity: Q2 2020 in Review
66 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q2 2020, worth a combined $12.4M — up 305% from $3.05M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new AYTU positions and 9 closed out — a net gain of 33 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5.53M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $368K sold.
- 66 institutional investors held AYTU BioPharma (AYTU) as of Q2 2020, up from 33 in Q1 2020.
- Funds reported $12.4M of AYTU BioPharma stock for Q2 2020, up 305% quarter-over-quarter.
- 42 funds opened new AYTU BioPharma positions in Q2 2020 and 9 closed out, a net change of +33 holders.
- The largest AYTU BioPharma buyer in Q2 2020 was Vanguard Group, an estimated $5.53M added.
- The largest AYTU BioPharma seller in Q2 2020 was Susquehanna International Group, an estimated $368K sold.
Based on aggregated 13F filings for Q2 2020.